14 Dec 2015 --- Seventure Partners, a European leader in financing innovation, has announced the completion of a new closing for Health for Life Capital, the first investment vehicle in the world to anticipate the microbiome revolution in the fields of health and nutrition, with Novartis Pharma AG agreeing to participate. This closing will increase the total amount of funds available to €160Mio.
